Nutanix (NASDAQ: NTNX) shares were trading around 3% higher after-hours following the company’s reported Q2 results, with EPS coming in at ($0.03), better than the Street estimate of ($0.19). Revenue grew 19% year-over-year to $413.1 million, compared to the Street estimate of $406.89 million.

The company expects Q3/22 revenue in the range of $395-400 million, compared to the consensus of $400.92 million. ACV Billings are expected to be $195 - $200 million.

For the full 2022-year, the company expects revenue in the range of $1.625-1.63 billion, compared to the consensus of $1.63 billion. ACV Billings are expected to be $760 - $765 million.